|Day Low/High||0.25 / 0.28|
|52 Wk Low/High||0.24 / 1.96|
NSI-189 Shows Prevention and Reversal of Diabetic Neuropathies in Mice
Dr. Karl Johe Resigns from Board of Directors; Company Announces Creation of Scientific Policy Committee with Dr. Johe as Chairman
Data Contribute to Understanding NSI-189 Mechanism of Action
These under-$10 stocks are ready to move higher from current levels. Here's how to trade them from here.
Trial Efficacy Endpoints Include Reduction in Depression and Cognition Improvement
NSI-566 Trial Data Reveals Biological Activity Across Multiple Neurodegenerative Diseases: ALS, Chronic Spinal Cord Injury, and Stroke
A much-hyped press conference reveals nothing new about Brainstorm's stem-cell therapy for ALS.
Phase 1b Data Demonstrate Potential of Oral Neurogenesis-based Therapies
Stocks with insider trader activity include TIPT, VER and CUR
Stocks with insider trader activity include VLGEA, GOOD and CUR
Stocks with insider trader activity include IEX, SCOR and CUR